Blood 2014;123:2485 93. 46. Warkentin TE, Greinacher A, Koster A, Lincoff AM. Treatment and prevention of heparin-induced thrombocy- topenia: American College of Chest Physicians evidence- based clinical practice guidelines (8th edition). Chest 2008;133(Suppl):340 80. 47. Lubenow N, Kempf R, Eichner A, Eichler P, Carlsson LE, Greinacher A. Heparin-induced thrombocytopenia: tem- poral pattern of thrombocytopenia in relation to initial use or reexposure to heparin. Chest 2002;122:37 42. 48. Warkentin TE, Kelton JG. A 14-year study of heparin- induced thrombocytopenia. Am J Med 1996;101:502 7. 49. Nuttall GA, Oliver WC, Santrach PJ, et al. Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmo- nary bypass: a prospective observational case series. Anesth Analg 2003;96:344 50. 50. Potzsch B, Klovekorn WP, Madlener K. Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia. N Engl J Med 2000;343: 515. 51. Warkentin TE, Arnold DM, Nazi I, Kelton JG. The platelet serotonin-release assay. Am J Hematol 2015;90:564 72. 52. Warkentin TE. Heparin-induced thrombocytopenia in crit- ically ill patients. Semin Thromb Hemost 2015;41:49 60. 53. Piednoir P, Allou N, Provenchere S, et al. Heparin-induced thrombocytopenia after cardiac surgery: an observational study of 1,722 patients. J Cardiothorac Vasc Anesth 2012;26: 585 90. 54. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006;4:759 65. 55. Lillo-Le Louet A, Boutouyrie P, Alhenc-Gelas M, et al. Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass. J Thromb Haemost 2004;2: 1882 8. 56. Cuker A, Arepally G, Crowther MA, et al. 